Madrigal Pharmaceuticals, Inc. (MDGL)
NASDAQ: MDGL · Real-Time Price · USD
516.56
+3.35 (0.65%)
Sep 25, 2026, 4:00 PM EDT - Market closed
Madrigal Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 292.73 | 198.69 | 100.02 | 99.92 | 331.55 | 36.27 |
Short-Term Investments | 546.03 | 784.87 | 826.23 | 534.22 | 27.23 | 234.08 |
Cash & Short-Term Investments | 838.75 | 983.56 | 926.25 | 634.13 | 358.77 | 270.35 |
Cash Growth | 5.24% | 6.19% | 46.07% | 76.75% | 32.71% | -4.86% |
Accounts Receivable | 192.31 | 134.48 | 53.82 | - | - | - |
Receivables | 192.31 | 134.48 | 53.82 | - | - | - |
Inventory | 99.39 | 74.84 | 34.07 | - | - | - |
Prepaid Expenses | 68.57 | 47.8 | 13.79 | 3.15 | 2.6 | 1.34 |
Restricted Cash | 0.16 | 5.09 | 5 | - | - | - |
Total Current Assets | 1,199 | 1,246 | 1,033 | 637.28 | 361.37 | 271.68 |
Property, Plant & Equipment | 17.17 | 6.44 | 4.59 | 3.27 | 1.2 | 1.65 |
Other Intangible Assets | 7.19 | 7.38 | 4.73 | - | - | - |
Total Assets | 1,245 | 1,260 | 1,042 | 640.55 | 362.57 | 273.33 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 34.51 | 48.88 | 43.6 | 28.04 | 23.83 | 21.38 |
Accrued Expenses | 338.66 | 260.39 | 124.7 | 89.98 | 91.46 | 55.05 |
Current Portion of Leases | 1.03 | 1.02 | 0.98 | 0.53 | 0.6 | 0.41 |
Total Current Liabilities | 374.2 | 310.29 | 169.28 | 118.55 | 115.89 | 76.84 |
Long-Term Debt | 340.79 | 339.88 | 117.57 | 115.48 | 49.29 | - |
Long-Term Leases | 5.92 | 6.73 | 1.02 | 1.19 | - | 0.39 |
Total Liabilities | 720.92 | 656.9 | 287.86 | 235.21 | 165.18 | 77.23 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0 | 0 | 0 | 0 | 0 | 0 |
Additional Paid-In Capital | 2,766 | 2,692 | 2,556 | 1,741 | 1,160 | 863.5 |
Retained Earnings | -2,243 | -2,090 | -1,802 | -1,336 | -962.66 | -667.31 |
Comprehensive Income & Other | 0.81 | 0.87 | 0.47 | 0.47 | -0.03 | -0.08 |
Shareholders' Equity | 523.72 | 602.69 | 754.38 | 405.33 | 197.39 | 196.11 |
Total Liabilities & Equity | 1,245 | 1,260 | 1,042 | 640.55 | 362.57 | 273.33 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 347.75 | 347.63 | 119.57 | 117.19 | 49.89 | 0.8 |
Net Cash (Debt) | 491 | 635.93 | 806.68 | 516.94 | 308.88 | 269.55 |
Net Cash Growth | -27.05% | -21.17% | 56.05% | 67.36% | 14.59% | -4.88% |
Net Cash Per Share | 21.47 | 28.35 | 37.92 | 27.66 | 18.02 | 16.30 |
Filing Date Shares Outstanding | 23.1 | 22.94 | 22.08 | 19.9 | 18.14 | 17.1 |
Total Common Shares Outstanding | 23.09 | 22.84 | 22 | 19.88 | 18.1 | 17.1 |
Working Capital | 824.98 | 935.48 | 863.65 | 518.73 | 245.48 | 194.85 |
Book Value Per Share | 22.68 | 26.39 | 34.28 | 20.39 | 10.90 | 11.47 |
Tangible Book Value | 516.54 | 595.31 | 749.65 | 405.33 | 197.39 | 196.11 |
Tangible Book Value Per Share | 22.37 | 26.06 | 34.07 | 20.39 | 10.90 | 11.47 |